Advertisement
News
Subscribe to MDT Magazine News

Investment in Oncology Drug Development Remains Strong as 133 Companies Initiate Late-Stage Clinical Trials Representing a 21% Increase

June 2, 2011 6:32 am | by Bio-Medicine.Org | Comments

NEW YORK, June 2, 2011 /- Citeline, the world's leading research authority on pharmaceutical clinical trials and intelligence recently completed a comprehensive review of clinical trial starts in the oncology therapeutic area to uncover trends and patterns in drug development. Over the...

Benchmark Electronics Recognized as Supplier for 2011 Design Medical Excellence Award Winner

June 2, 2011 6:32 am | by Bio-Medicine.Org | Comments

ANGLETON, Texas, June 2, 2011 /- Benchmark Electronics, Inc. (NYSE: BHE ), a leading integrated contract manufacturing provider, announced today that a product it helped commercialize and currently manufactures has won the 2011 Medical Design Excellence Award and 2011 Edison Award for...

TOPICS:

Analyst upgrades Affymetrix on incoming CEO

June 2, 2011 5:45 am | by The Associated Press | Comments

An analyst upgraded shares of genetic test maker Affymetrix Inc. Thursday after the company appointed a new chief executive with significant experience in the life sciences industry.Baird analyst Quintin Lai upgraded company shares to "outperform" on expectations that incoming CEO Frank Witney...

Advertisement

Lumicell lands $2.7M in first funding round

June 2, 2011 5:34 am | by Mass High Tech: The Journal of New England Technology | Comments

Lumicell Diagnostics Inc., a Waltham company that is developing a handheld device that can detect any cancer cells left behind after a cancer surgery, has raised $2.7 of a planned $3.9 million financing round, according to federal documents.

Hologic buys Chinese distributor TCT International for $135M

June 2, 2011 5:34 am | by Mass High Tech: The Journal of New England Technology | Comments

Hologic Inc., a Bedford medical imaging and diagnostics product developer focused on women's health, has paid $135 million cash to acquire TCT International Co. Ltd., a medical products distributor in Beijing, China.

Cynosure to Present at Jefferies 2011 Global Healthcare Conference

June 2, 2011 5:33 am | by Bio-Medicine.Org | Comments

WESTFORD, Mass., June 2, 2011 /- Cynosure, Inc. (NASDAQ: CYNO ), a leader in laser- and light-based treatments for minimally invasive and non-invasive aesthetic applications, today announced that it will present at the Jefferies 2011 Global Healthcare Conference at 1:30 p.m. (ET) on...

TOPICS:

Isis Pharmaceuticals to Present at the Jefferies 2011 Global Healthcare Conference

June 2, 2011 5:32 am | by Bio-Medicine.Org | Comments

CARLSBAD, Calif., June 2, 2011 /- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ), the leader in antisense therapeutics, today announced that management will present a company overview at Jefferies' 2011 Global Healthcare Conference on Thursday, June 09, 2011 at 11:30 a.m. ET at the Grand...

TOPICS:

PLC Ramps Up for U.S. Clinical Trial of RenalGuard®

June 2, 2011 5:32 am | by Bio-Medicine.Org | Comments

FRANKLIN, Mass., June 2, 2011 /- PLC Systems Inc. (OTCBB: PLCSF), a company focused on innovative medical device technologies, today announced that it is preparing to commence the pivotal trial in the U.S. for the company's innovative product, RenalGuard®, to seek approval for sales...

TOPICS:
Advertisement

Syndax Pharmaceuticals Announces Issuance of US Patent for Entinostat

June 2, 2011 5:32 am | by Bio-Medicine.Org | Comments

WALTHAM, Mass., June 2, 2011 /- Syndax Pharmaceuticals, a clinical-stage epigenetics oncology company, today announced allowance by the United States Patent and Trademark Office of Patent Application Serial No. 12/549458 entitled: " N-(2-AMINOPHENYL)-4[N-(PYRIDINE-3-YL)-...

PositiveID Corporation's Pipeline Increases to Over $37 Million in Potential New Government Contracts

June 2, 2011 5:31 am | by PositiveID | Comments

PositiveID Corporation's Pipeline Increases to Over $37 Million in Potential New Government Contracts

TOPICS:

Soligenix Appoints Joseph Warusz as Vice President of Administration and Controller

June 2, 2011 3:33 am | by Bio-Medicine.Org | Comments

PRINCETON, N.J., June 2, 2011 /- Soligenix, Inc. (OTCBB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company, announced today that it recently appointed Joseph Warusz as its new Vice President of Administration and Controller. In this role, Mr. Warusz will oversee the...

TOPICS:

Cyberonics Reports Record Fiscal 2011 Results and Provides Fiscal 2012 Guidance

June 2, 2011 3:33 am | by Bio-Medicine.Org | Comments

HOUSTON, June 2, 2011 /- Cyberonics, Inc. (NASDAQ: CYBX ), a global leader in epilepsy management, today announced results for the fourth quarter and fiscal year ended April 29, 2011.   Annual HighlightsOperating results for the fifty-two week fiscal 2011 compared with the...

TOPICS:

MedeAnalytics Launches Value-Based Purchasing Resource Center

June 2, 2011 3:33 am | by Bio-Medicine.Org | Comments

EMERYVILLE, Calif., June 2, 2011 /- MedeAnalytics, a leading provider of healthcare performance management solutions, announced today the launch of its Value-Based Purchasing Resource Center. As a service to the healthcare industry, the resource center provides objective educational...

TOPICS:

Roche and Clovis Oncology to Co-Develop EGFR Companion Diagnostic

June 2, 2011 3:31 am | by Bio-Medicine.Org | Comments

BOULDER, Colo., and PLEASANTON, Calif., June 2, 2011 /- Clovis Oncology, Inc. and Roche (SIX: RO, ROG; OTCQX: RHHBY), announced today that they have entered into an agreement to develop an in vitro PCR (Polymerase Chain Reaction) based companion diagnostic test. The goal is to identify...

China Kanghui Holdings Announces Participation in Upcoming Investor Conferences

June 2, 2011 2:34 am | by Bio-Medicine.Org | Comments

CHANGZHOU, China, June 2, 2011 /PRNewswire-Asia/ -- China Kanghui Holdings (NYSE: KH ) ("Kanghui" or the "Company"), a leading domestic developer, manufacturer and marketer of orthopedic implants in China, today announced its participation in the following investor events: Jefferies 2011...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading